National
Jackson wants GOP to focus on marriage
CPAC panel emphasizes opposition to same-sex nuptials
Two black conservatives are urging the Republican Party to emphasize social issues — such as opposition to same-sex marriage — to build appeal for the GOP among racial minority groups.
Bishop Harry Jackson of the Hope Christian Church, known for leading efforts against legalizing same-sex marriage in D.C., and Rev. Michael Faulkner, author of “Restoring the American Dream,” called for greater attention to social issues at the 2011 Conservative Political Action Conference in D.C.
During a panel titled “Traditional Marriage and Society,” Jackson said the conservative movement has “an opportunity to engage a multi-racial, multi-cultural group of people,” but only if the Republican Party doesn’t throw social issues “under the bus.”
“Whether I like the GOP or not, whether I like Republicans or not, there is no other party now that really is advocating any of the social issues that are consistent with my faith,” Jackson said.
Faulkner, who campaigned against Rep. Charlie Rangel (D-N.Y.), said conservatives need to develop their message to racial minorities because they are ready to support the conservative movement.
“As I campaigned, especially in Latino churches, I was required before the pastor would allow me to speak to give my position on same-sex marriage and on abortion,” Faulkner said. “So they are staunch conservatives, probably more conservative than we are.”
Jackson spoke out against the advancement of marriage rights for gay couples and said it would interfere with parents’ rights in children’s education.
“If you change marriage, you redefine the family; if you redefine the family, you redefine parenting; if you redefine parenting, you must of necessity, redefine education, and in that redefinition, that’s where we get ‘Heather Has Two Mommies’ and a generation of kids as young as five-years-old are told that they are to be gay allies in the State of California,” Jackson said.
Faulker also railed against the advancement of gay nuptials and said pressure to be politically correct can’t change marriage.
“We need to stand for traditional marriage,” Faulkner said. “Not just stand against anyone else, but to stand for our society, stand for our culture, stand for our nation, stand for the children and the families in our nation. If we do not, we will indeed destroy ourselves.”
One LGBT rights group, on the other hand, says that Republicans must continue emphasizing fiscal issues as opposed to social issues to win support among the American public.
R. Clarke Cooper, executive director of the Log Cabin Republicans, said the focus of most conservatives is the economy as some within the movement continue to rail against same-sex marriage.
“There are going to be members of the conservative movement who are still going to hold social issues as their No. 1 focus, but what we saw at CPAC this last year was that was not the primary focus,” Cooper said.
Cooper pointed to the results of CPAC straw poll, which showed that same-sex marriage wasn’t a major concern among attendees.
Support for “protecting tradional marriage” was a priority for 3 percent of straw poll responders. Meanwhile, 53 percent of attendees said reducing the size of the federal government was a priority and 38 percent said reducing government spending was a priority.
Also during the panel discussion, Tom Minnery, senior president of government and public policy for CitizenLink, offered statistics that he said demonstrate countries with same-sex marriage are worse off than places that deny marriage rights to gay couples. LGBT advocates have long disputed the statistical accuracy of Minnery’s work.
Minnery said responders to a survey were asked whether married people were happier in countries with varying levels of relationship recognition for same-sex couples.
According to Minnery, in countries with same-sex marriage, 21 percent of responders said married people were happier; in countries with civil unions; 36 percent say married people are happier; in countries with only regional recognition, 42 percent of people said married people were happier; and in countries with no same-sex marriage, the respect for marriage “goes high.”
For another question on whether children need both a mother and a father to be happy, Minnery said 76 percent of responders said “yes” in countries with same-sex marriage; 80 percent of responders said “yes” in nations with regional recognition; and 93.8 percent of responders said “yes” in countries with no same-sex marriage.
“As the marriage culture in a country declines, the respect for marriage and the belief in its power also declines,” Minnery said. “That’s why our organization continues to believe if this country loses our marriage culture, we’re headed for a lot of trouble.”
In response, Gary Gates, a scholar at the Williams Institute, a think tank on sexual orientation law at the University of California, Los Angeles, said that in the United States, divorce rates are lower in places where same-sex marriage is legal.
“That doesn’t directly say people are quote, happier, but heterosexual relationships are more stable in places where same-sex couples can get married,” Gates said.
According to data last year from U.S. Census Bureau, in Massachusetts, where same-sex marriage has been legal since 2003, the divorce rate is 1.8 percent — the lowest in the nation.
With regard to statistics on having a mother and father being important for children, Gates said just because people have that belief doesn’t make it true.
“I just saw a report today: 50 percent of Republicans believe that Obama isn’t a natural-born citizen,” Gates said. “Because people believe it, doesn’t make it true.”
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:

